scholarly journals Factitious administration of analogue insulin to a 2-year-old child

2016 ◽  
Vol 16 (2) ◽  
pp. 82 ◽  
Author(s):  
Nehal Thanawala ◽  
Sarah Cheney ◽  
Gwen Wark ◽  
Mario Thevis ◽  
Andreas Thomas ◽  
...  
Keyword(s):  
Analogue Insulin

scholarly journals Pharmacological and clinical profiles of new soluble basal insulin analogue, Insulin Detemir (Levemir®)

2008 ◽  
Vol 132 (3) ◽  
pp. 181-188 ◽  
Author(s):  
Yasuyuki Katayama ◽  
Akihiro Inoue ◽  
Hiroaki Horigome
Keyword(s):  
Basal Insulin ◽  
Insulin Detemir ◽  
Insulin Analogue ◽  
Analogue Insulin ◽  
Clinical Profiles

scholarly journals PDB23 Economic Impact of Analogue Insulin on Health Expenditure at the Mexican Institute of Social Security in 2012. An Expenditure Reduction Proposal

2012 ◽  
Vol 15 (7) ◽  
pp. A497
Author(s):  
P. Panopoulou ◽  
F. Garcia-Contreras ◽  
J.A. Paladio-Hernandez ◽  
J.L. Huerta ◽  
E. Gonzalez Pier
Keyword(s):  
Social Security ◽  
Economic Impact ◽  
Health Expenditure ◽  
Analogue Insulin ◽  
Expenditure Reduction

scholarly journals Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine

2004 ◽  
Vol 8 (45) ◽  
Author(s):  
E Warren ◽  
E Weatherley-Jones ◽  
J Chilcott ◽  
C Beverley
Keyword(s):  
Systematic Review ◽  
Economic Evaluation ◽  
Insulin Glargine ◽  
Insulin Analogue ◽  
Analogue Insulin ◽  
Acting Insulin ◽  
Long Acting

Clinical experiences with basal analogue insulin in routine care. Retrospective follow up analysis of a database from daily routine care

2013 ◽  
Vol 154 (37) ◽  
pp. 1476-1484
Author(s):  
Zsolt Sudár ◽  
Lajos Muth ◽  
Csaba Nyirati ◽  
Vince Szí ◽  
János Tornóczky ◽  
...  
Keyword(s):  
Body Weight ◽  
Metabolic Control ◽  
Human Insulin ◽  
Insulin Dose ◽  
Routine Care ◽  
Analogue Insulin ◽  
Bolus Insulin ◽  
Basal Bolus

Introduction: Basal-bolus insulin regime is frequently used in type 2 diabetes in order to improve metabolic control and decrease the risk of complications. A general question is, however, the effect of application of analogue insulin in comparison to human insulin regimes. Aim: The aim of the authors was to perform a retrospective database analysis among patients who were switched from human insulin only based basal-bolus regime to analogue only insulin regime in order to examine changes in metabolic control, body weight, insulin dose and basal:bolus insulin ratio. Method: Type 2 diabetic patients (n = 137) were enrolled who used once daily basal insulin with complementary bolus insulin given at main meals, and human insulin was switched to analogue insulin. Patients were divided into two groups using detemir (n = 103) or glargine (n = 34). Results: During 17 months ofanalogue insulin treatment the HbA1c was decreased by 0.34% (detemir –0.44%; glargine –0.17%). Body weight was increased by 1.11 kg (detemir +1.0 kg; glargine +1.43 kg). The basal:bolus insulin ratio increased in all groups (entire cohort 6.04%, detemir 5.26%, glargine 8.37%). The average insulin dose was 80.76 units at the end of follow up. There was no significant difference in terms of total and basal insulin doses between detemir (27.89 and 79.78 U, respectively) and glargine group (32.85 and 83.74 U, respectively). Conclusions: These results support that switching from human to analogue insulin in basal-bolus regime could improve the metabolic control by increasing dose of basal analogue insulin and basal: bolus ratio. Both detemir and glargine can provide similar improvement in metabolic control with the same insulin dose but with relatively more weight gain with glargine. Orv. Hetil., 2013, 154, 1476–1484.

Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes

2003 ◽  
Vol 20 (8) ◽  
pp. 626-634 ◽  
Author(s):  
U. Bott ◽  
S. Ebrahim ◽  
S. Hirschberger ◽  
S. E. Skovlund
Keyword(s):  
Quality Of Life ◽  
Type 1 Diabetes ◽  
Insulin Aspart ◽  
Treatment Satisfaction ◽  
Insulin Analogue ◽  
Analogue Insulin ◽  
Acting Insulin

Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine

2000 ◽  
Vol 2 (6) ◽  
pp. 373-383 ◽  
Author(s):  
S. Dagogo-Jack ◽  
H. Askari ◽  
B. Morrill ◽  
L. L. Lehner ◽  
B. Kim ◽  
...  
Keyword(s):  
Insulin Glargine ◽  
Human Insulin ◽  
Physiological Responses ◽  
Regular Human Insulin ◽  
Analogue Insulin

A new generation ultra-long-acting insulin analogue-insulin degludec

2013 ◽  
Vol 13 (1) ◽  
pp. 6-8
Author(s):  
YuPu HUANG ◽  
Qin ZHANG ◽  
LanXin WANG ◽  
Wei CHEN
Keyword(s):  
Insulin Analogue ◽  
Insulin Degludec ◽  
Analogue Insulin ◽  
Acting Insulin ◽  
Long Acting ◽  
New Generation
Sign in / Sign up

Export Citation Format

Share Document